BML Investment Partners, L.P.

Holdings History for ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP)

Symbol: ORMP on Nasdaq
Investment type: Equity / Common Stock par value $0.012 per share
Latest Disclosed Shares Owned: 3,287,531 shares
Security Ownership %: 8.3%

Leonard Braden Michael ownership in ORAMED PHARMACEUTICALS INC. Common Stock par value $0.012 per share (ORMP)

09 Feb 2026 - Leonard Braden Michael has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,287,531 shares of ORAMED PHARMACEUTICALS INC. Common Stock par value $0.012 per share (ORMP). This represents 8.3% ownership of the company. In their previous filing dated 13 Feb 2025, BML Investment Partners, L.P. had reported owning 2,643,907 shares, indicating an increase of +24%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Leonard Braden Michael	8.3%	+25%	$11,276,231	3,287,531	+643,624	+24%	$3.43	13G/A	31 Dec 2025	09 Feb 2026, 14:13
BML Investment Partners, L.P.	6.6%		$5,816,595	2,643,907			$2.20	13G/A	31 Dec 2024	13 Feb 2025, 16:41